These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 935246)

  • 1. Action of naloxone on the interferon-lowering activity of morphine in the mouse.
    Geber WF; Lefkowitz SS; Hung CY
    Pharmacology; 1976; 14(4):322-9. PubMed ID: 935246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of spleen in the interferon-lowering action of morphine.
    Geber WF; Lefkowitz SS; Hung CY
    Gen Pharmacol; 1976 Sep; 7(4):255-8. PubMed ID: 976739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of polyinosinic-polycytidylic acid (Poly I:C) on naloxone-precipitated withdrawal in morphine-dependent mice.
    Chen L; Zhai H; Lu L; Chen S; Ning Y; Wang W
    Neurosci Lett; 2011 Jan; 487(3):341-4. PubMed ID: 20974220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K; Murphy NP
    Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of interferon inhibition following single and multiple injections of morphine.
    Geber WF; Lefkowitz SS; Hung CY
    J Toxicol Environ Health; 1977 Jan; 2(3):577-82. PubMed ID: 846006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of the pupillary actions of morphine and naloxone.
    Rabinowitz R; Korczyn AD
    J Ocul Pharmacol; 1987; 3(1):17-21. PubMed ID: 3503906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
    Holmes BB; Fujimoto JM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of histamine receptors in morphine-induced increased naloxone potency in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):69-74. PubMed ID: 3990446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine and naloxone reverse the effect of intrathecal morphine on the canine urinary bladder.
    Drenger B; Caine M; Sosnovsky M; Magora F
    Eur J Anaesthesiol; 1987 Sep; 4(5):375-82. PubMed ID: 3428282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
    Van Vugt DA; Baby N; Stewart M; Reid RL
    Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycaemia, a morphine-like effect produced by naloxone in the cat.
    Feldberg W; Pyke DA; Stubbs WA
    J Physiol; 1983 Jul; 340():121-8. PubMed ID: 6887043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latency to first naloxone-induced jump as a measure of precipitated abstinence intensity in morphine-dependent mice and the interaction of set on this test.
    Miller JM; Poulsen-Burke J; Cochin J
    Life Sci; 1983 May; 32(19):2205-13. PubMed ID: 6843292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrahippocampally-injected naloxone and morphine upon behavioural responses to novelty in mice from two selectively-bred lines.
    van Abeelen JH; van Nies JH
    Psychopharmacology (Berl); 1983; 81(3):232-5. PubMed ID: 6417711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of simultaneous administration of morphine and naloxone on the exploratory behavior of mice].
    Torre E; Fassino S; Varetto B
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1472-7. PubMed ID: 7165756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.